ERIN DOHERTY to Antibodies, Bispecific
This is a "connection" page, showing publications ERIN DOHERTY has written about Antibodies, Bispecific.
Connection Strength
0.214
-
Blinatumomab Therapy Is Associated with Favorable Outcomes after Allogeneic Hematopoietic Cell Transplantation in Pediatric Patients with B Cell Acute Lymphoblastic Leukemia. Transplant Cell Ther. 2024 Feb; 30(2):217-227.
Score: 0.214